# Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis

> **NCT02769130** · PHASE1,PHASE2 · SUSPENDED · sponsor: **The Hospital for Sick Children** · enrollment: 40 (estimated)

## Conditions studied

- Pulmonary Vein Stenosis
- Children

## Interventions

- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT02769130
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2016-05
- **Primary completion:** 2021-05
- **Final completion:** 2021-05
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** Due to Health Canada losartan recall, a new formulation being added to the protocol/ temporary suspension
- **Last updated:** 2019-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02769130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02769130, "Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02769130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*